194 related articles for article (PubMed ID: 30257407)
1. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
Kayani Z; Bordbar AK; Firuzi O
Biomed Pharmacother; 2018 Nov; 107():945-956. PubMed ID: 30257407
[TBL] [Abstract][Full Text] [Related]
2. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines.
Banu H; Sethi DK; Edgar A; Sheriff A; Rayees N; Renuka N; Faheem SM; Premkumar K; Vasanthakumar G
J Photochem Photobiol B; 2015 Aug; 149():116-28. PubMed ID: 26057021
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
5. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
7. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
[TBL] [Abstract][Full Text] [Related]
8. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
9. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
[TBL] [Abstract][Full Text] [Related]
10. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
11. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and trastuzumab conjugated redox responsive random multiblock copolymeric nanocarriers for breast cancer therapy: In-vitro and in-vivo studies.
Kumar A; Lale SV; Aji Alex MR; Choudhary V; Koul V
Colloids Surf B Biointerfaces; 2017 Jan; 149():369-378. PubMed ID: 27846450
[TBL] [Abstract][Full Text] [Related]
13. Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer.
Fazilati M
Cell Biol Int; 2014 Feb; 38(2):154-63. PubMed ID: 23956031
[TBL] [Abstract][Full Text] [Related]
14. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
15. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
16. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
17. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
18. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment.
Khondee S; Chittasupho C; Tima S; Anuchapreeda S
Curr Drug Deliv; 2018; 15(3):406-416. PubMed ID: 28707580
[TBL] [Abstract][Full Text] [Related]
20. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
